The American Medical Association urges greater transparency and oversight for imaging AI to maximize trust and patient safety.
Key Details
- 1AMA passed a resolution advocating for explainable AI tools in radiology and other fields.
- 2The association calls for third-party oversight of AI algorithms rather than relying solely on vendor claims.
- 3AMA emphasizes the need for detailed explanations of AI outputs, especially given potential 'life or death consequences.'
- 4Intellectual property concerns should not outweigh the need for explainable AI in medicine.
- 5Lack of explainability may put physicians in difficult positions and undermine their clinical judgment.
Why It Matters
The AMA's stance highlights the critical need for trustworthy AI tools in radiology, impacting both provider decision-making and patient care. Increased transparency and oversight may shape future AI regulations, adoption, and industry practices.
Source
Radiology Business
Related News
•Radiology Business
NCCN Endorses AI Risk Tools for Breast Cancer Screening
NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
•Radiology Business
ACR Expands Resources for Radiology Practices to Assess Imaging AI
The ACR is offering new tools to help radiology practices evaluate and monitor imaging AI algorithms.
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.